Advertisement

Get Topic Updates

Share

Written by the OrganizedWisdom Team with as the reviewer. All original content is supervised by the The OrganizedWisdom Medical Review Team

genengnews.com

1 of 0

Resource Description:

HGS and GlaxoSmithKline's systemic lupus erythematosus (SLE) drug candidate, Benlysta, met its primary endpoint in its second (Bliss-76) Phase III trial.

« Back to the New Lupus Drug Shows Promise WisdomCard

Related Health Centers:

Retrieved from "http://www.organizedwisdom.com/Special:OW_Special_Nugget"

Advertisement

Health Centers

Wellness Centers

Living Centers